Hey guys Serg here, we've got breaking breaking news
Roche
Pharmaceuticals is set to buy flat iron health
Both of these is our armpit is an important move in the clinical research space Roche is a big
Sponsor pharmaceutical company they create drugs they make they're from Switzerland and
They're a big sponsor in the community in the space. I know probably many of you have worked on trials for them
I know I have they do a lot of drug trials and
This is a big move. They bought them straight up for 1.9. Billion dollars
They acquire flat iron health and flat iron health is actually a start-up, and it's backed by Google's alphabet
You know Google Ventures
Alphabets the parent company, then there's Google underneath it and then there's Google Ventures
Which is a subsidiary of Google and they partially funded?
Flatiron Health and
Roche is coming in they had already had a 22% investment in flattering health
But they're coming in and buying the rest of it for 1.9 billion
so this is a big move and
Flatiron health what they do is they're a data company
For cancer and a lot of you guys know that in clinical research
Oncology is the biggest sector
That's where most the money a lot of the money is made so if you can get into the oncology side of things you definitely
Want to do that, but there's a lot more
Involvement with that as well
so
Big move for roasts they bought Flatiron Health a data company now if you remember now
quintiles
Did a merger with IMS Health which is also a data company?
So data data data is going to be very important for the industry of course quintiles. Well iqv and now is a
CRO they're on the CRO side of things, but they partnered with ims to offer more
products to four other companies because typically the CRO is a one-trick pony and
You want to really pretty much expand your offerings if you can
So they part they partnered with IMS another data company
but Roche partnered with flat iron
They bought flat iron a big data company, and they work predominantly with electronic health records
So there's a lot of data. That's still to be
That still needs to be known in the industry and of course
We've got data data coming from all angles just think about it this way
Your car is gonna. Be pretty soon collecting data. If not already
I know if you probably own a test law your car is constantly sending data with autonomous driving
We're gonna be there can be cameras everywhere looking at data looking at patterns looking at signs
Your phone is gonna be able to transmit data back to better enhance the product so it's gonna be the same thing in the biopharmaceutical
space
More and more data, so if you're looking at electronic health record you're gonna be able to say okay this patient took
You know Herceptin?
And it worked or this new drug worked in
60% of the patients
but what happened to the other 40% and they're gonna really be able to delve into that forty percent really parse between the
nitty-gritty details, they're gonna be a look at their DNA profile their RNA profile and
really
Parse between those details of okay? Why didn't this work or why did this work, and that's not possible now?
But you've got more and more data companies coming into the fray
because
That information is very important
And you know can lead to individualized medicine
Moreso of that and can lead to really understanding why drugs work for certain people, and why they don't for other people so
big move by Roche to purchase Flatiron Health with let's look for the remainder of
2018 for more data companies to either get started in the space or more big
Conglomerates to go ahead and purchase their own data
subsidiary to analyze this data and provide better product offerings for their services, so
Big move by Roche guys just wanted to mention that we're going to be doing a lot more industry news here on this channel
So and pretty much, we're gonna try and get it out when comes out so this just happened yesterday. This was announced yesterday
I'm sure that the talks have been in the talks for a while so
big move here
If you guys know any more details about the move
I'm sure it's I don't think it's set to close until the second quarter of 2018 and actually Flatirons night
It's gonna be as own separate entity so it's not gonna be just working with Roche
They're gonna be owned by Roche, but they're gonna be working with other life science brands as well
so
That's important to keep in mind
So we'll keep a lookout out for this
For this move and see what really happens see what Roche is able to do with it
I'm excited that they're getting into the data space. It's very important. I think if you're in the data management data analytics space
You're gonna be in for a wild ride over these next 10 to 15 years
I think that's probably one of the best spaces to be in with just so much data coming in
We're gonna need people to be that are gonna be able to analyze that data and know what they're talking about so
That's it for this video guys as always email us at elite clinical group at gmail.com
and
Comment down below what you guys think of this move?
Good/bad, what do you think about data big data coming to clinical research comment down below?
so
That's it for this video guys take care